Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TARSONS PRODUCTS Gains 5%; BSE HEALTHCARE Index Down 0.2%
Tue, 17 Sep 10:57

TARSONS PRODUCTS Gains 5%; BSE HEALTHCARE Index Down 0.2%Image source: Chunumunu/www.istockphoto.com

TARSONS PRODUCTS share price has zoomed 5% and is presently trading at Rs 461.5.

Meanwhile, the BSE HEALTHCARE index is at 44,289.3 (down 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 1.6%) and Divis Laboratories (up 1.0%).

Biocon (down 2.4%) and KIMS (down 2.2%) are among the top losers today.

Over the last one year, TARSONS PRODUCTS has moved down from Rs 527.8 to Rs 461.5, registering a loss of Rs 66.3 (down 12.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,434.4 to 44,289.3, registering a gain of 55.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 172.8%), SUVEN PHARMACEUTICALS (up 124.0%) and Glenmark Pharma (up 100.7%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 82,984.8 .

The top losers among the BSE Sensex today are Tata Motors (down 2.1%) and MUNDRA PORT & SEZ (down 1.1%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.

In the meantime, NSE Nifty is at 25,412.3 (up 0.1%). Hero Motocorp and Divis Laboratories are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,467.0 to 82,984.8, registering a gain of 15,517.8 points (up 23.0%).

TARSONS PRODUCTS Financial Update...

TARSONS PRODUCTS net profit fell 58.1% YoY to Rs 40 million for the quarter ended June 2024, compared to a profit of Rs 96 million a year ago. Net sales rose 35.5% to Rs 848 million during the period as against Rs 626 million in April-June 2023.

For the year ended March 2023, TARSONS PRODUCTS reported 19.8% decrease in net profit to Rs 807 million compared to net profit of Rs 1,007 million during FY22. Revenue of the company fell 5.8% to Rs 2,832 million during FY23.

The current Price to earnings ratio of TARSONS PRODUCTS, based on rolling 12 month earnings, stands at 66.3.


Equitymaster requests your view! Post a comment on "TARSONS PRODUCTS Gains 5%; BSE HEALTHCARE Index Down 0.2%". Click here!